Unidade Local De Saude De Santa Maria E.P.E.

Az itteni vizsgálatok

Miről szól a helyszín 229 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek

• Tüdőrák18 vizsgálat
• Crohn-betegség11 vizsgálat
• Sjögren-szindróma11 vizsgálat
• Áttétes emlőrák10 vizsgálat
• Magas vérnyomás10 vizsgálat
• Pulmonális artériás hipertónia8 vizsgálat
• Szisztémás szklerózis (szkleroderma)8 vizsgálat
• Alzheimer-kór7 vizsgálat
• Arthritis psoriatica7 vizsgálat
• Asztma7 vizsgálat
• Colitis ulcerosa7 vizsgálat
• Sclerosis multiplex (SM)7 vizsgálat
• és még 69

Fázis

• 3. fázis176 vizsgálat
• 2. fázis28 vizsgálat
• 2/3. fázis12 vizsgálat
• 4. fázis5 vizsgálat
• 1. fázis3 vizsgálat
• 1/2. fázis2 vizsgálat

Állapot

• Lezárult66 vizsgálat
• Toboroz63 vizsgálat
• Fut, nem toboroz57 vizsgálat
• Még nem toboroz41 vizsgálat
• Felfüggesztve2 vizsgálat

Fő szponzor

• Janssen Research & Development, LLC15 vizsgálat
• Merck Sharp & Dohme LLC15 vizsgálat
• Novartis Pharmaceuticals12 vizsgálat
• AstraZeneca10 vizsgálat
• Hoffmann-La Roche8 vizsgálat
• és még 95

Futó vizsgálatok

• Még nem toboroz

  A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination with Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants with First-Line Metastatic Pancreatic Ductal Adenocarcinoma

  2025-522563-15-00· 2/3. fázis· AbbVie Deutschland GmbH & Co. KG· Forrás

• Még nem toboroz

  Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

  NCT07441408· 3. fázis· Bristol-Myers Squibb· Forrás

• Még nem toboroz

  Safety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis

  2025-523400-72-00· 2. fázis· Vertex Pharmaceuticals Inc.· Forrás

• Még nem toboroz

  To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)

  NCT07116473· 3. fázis· Eidos Therapeutics, a BridgeBio company· Forrás

• Még nem toboroz

  A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis

  NCT07873801· 3. fázis· Almirall, S.A.· Forrás

• Toboroz

  A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec

  NCT07444450· 3. fázis· Biogen· Forrás

• Toboroz

  Study of an Injectable Regimen of GS-3242 with Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment

  2026-526026-40-00· 2/3. fázis· Gilead Sciences Inc.· Forrás

• Toboroz

  A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular Disease

  NCT07843472· 3. fázis· Hoffmann-La Roche· Forrás

• Még nem toboroz

  Rollover Study for Participants Who Have Completed a Previous Clinical Study with Anifrolumab (Saphnelo) and Clinically Benefited from Continued Treatment.

  2026-526419-13-00· 3. fázis· AstraZeneca AB· Forrás

• Még nem toboroz

  A study that compares Depigoid Olea (a medication to treat olive pollen allergies) and placebo in patients who have a runny nose and pink and itchy eyes due to olive pollen allergy.

  2026-525840-13-00· 3. fázis· LETI Pharma S.L.U.· Forrás

• Toboroz

  A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus

  NCT07630714· 2. fázis· AstraZeneca· Forrás

• Toboroz

  A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

  NCT07705555· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

  NCT07737743· 2. fázis· Novartis Pharmaceuticals· Forrás

• Még nem toboroz

  A Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's Disease-associated Sensorimotor Polyneuropathy or Sensory Polyneuropathy (SERENITY)

  NCT07760818· 2. fázis· argenx· Forrás

• Toboroz

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  NCT07626411· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Toboroz

  A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

  NCT07711418· 3. fázis· Nektar Therapeutics· Forrás

• Toboroz

  A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis Bronchiectasis

  NCT07720375· 2. fázis· UCB Biopharma SRL· Forrás

• Toboroz

  A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer

  NCT07673887· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Toboroz

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

  NCT07544654· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Pridopidine Phase 3 Study in Huntington's Disease

  NCT07609108· 3. fázis· Prilenia· Forrás

• Toboroz

  A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)

  NCT07647510· 3. fázis· Dianthus Therapeutics· Forrás

• Toboroz

  A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3)

  2025-524404-29-00· 2. fázis· Eli Lilly & Co.· Forrás

• Toboroz

  Grass/Olive Immunotherapy for Rhinitis and Asthma (GOES)

  2025-521709-42-00· 3. fázis· LETI Pharma S.L.U.· Forrás

• Toboroz

  Grass Immunotherapy for Rhinitis and Asthma (GIRA)

  2025-521736-10-00· 3. fázis· LETI Pharma S.L.U.· Forrás

• Toboroz

  Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

  NCT07563881· 3. fázis· Rapport Therapeutics Inc.· Forrás

• Toboroz

  BIO|STREAM.CSP Study

  NCT07393009· Biotronik SE & Co. KG· Forrás

  Contact: Johannes Pfaffenberger

• Toboroz

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07577856· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

  NCT07577843· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

  NCT07525206· 3. fázis· AbbVie· Forrás

• Toboroz

  An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

  NCT07365332· 3. fázis· Inhibikase Therapeutics· Forrás

• Toboroz

  A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis

  2025-521546-23-00· 3. fázis· Novartis Pharma AG· Forrás

• Toboroz

  Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria

  2025-522878-36-00· 3. fázis· Celldex Therapeutics Inc.· Forrás

• Toboroz

  A Gaucher Disease Gene Therapy Trial With FLT201

  NCT07223944· 3. fázis· Spur Therapeutics· Forrás

• Toboroz

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

  NCT07430956· 3. fázis· Regeneron Pharmaceuticals· Forrás

• Meghívásos bevonás

  An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis

  NCT07459660· 2. fázis· MapLight Therapeutics· Forrás

• Toboroz

  A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

  NCT07326709· 3. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

  NCT07299019· 3. fázis· Zenas BioPharma (USA), LLC· Forrás

• Toboroz

  A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

  NCT07067463· 3. fázis· Zenas BioPharma (USA), LLC· Forrás

• Toboroz

  A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

  NCT07361510· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

  NCT07286058· 3. fázis· Takeda· Forrás

• Toboroz

  A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

  NCT07438496· 3. fázis· Janssen Research & Development, LLC· Forrás

• Még nem toboroz

  A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with psoriatic arthritis (PsA)

  2025-522471-28-00· 3. fázis· MoonLake Immunotherapeutics AG· Forrás

• Fut, nem toboroz

  A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

  NCT07107945· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

  NCT07276399· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

  NCT07276724· 3. fázis· Generate Biomedicines· Forrás

• Toboroz

  A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

  NCT06937229· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer

  NCT07278336· 1. fázis· AbbVie· Forrás

• Toboroz

  Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

  NCT07211958· 3. fázis· Syndax Pharmaceuticals· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

  NCT07174310· 3. fázis· Hoffmann-La Roche· Forrás

Showing 50 of 161.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Crohn-betegség10 toboroz
• Asztma6 toboroz
• Tüdőrák6 toboroz
• Alzheimer-kór5 toboroz
• Áttétes emlőrák5 toboroz
• Colitis ulcerosa5 toboroz
• Amiloidózis4 toboroz
• Gyomor- és nyelőcsőrák4 toboroz
• Petefészekrák4 toboroz
• Szívelégtelenség4 toboroz
• Arthritis psoriatica3 toboroz
• Hasnyálmirigyrák3 toboroz
• Lupus (SLE)3 toboroz
• Magas vérnyomás3 toboroz
• Pitvarfibrilláció3 toboroz
• Prosztatarák3 toboroz
• Sclerosis multiplex (SM)3 toboroz
• Stroke (szélütés)3 toboroz
• Vastagbélrák3 toboroz
• 2-es típusú cukorbetegség2 toboroz
• Aortic stenosis2 toboroz
• Atópiás dermatitisz (ekcéma)2 toboroz
• Cisztás fibrózis2 toboroz
• Elhízás2 toboroz
• Fej-nyaki daganatok2 toboroz
• Gyermekkori daganatok2 toboroz
• Huntington-kór2 toboroz
• Migrén2 toboroz
• Parkinson-kór2 toboroz
• Pulmonális artériás hipertónia2 toboroz
• Sjögren-szindróma2 toboroz
• Skizofrénia2 toboroz
• Szisztémás szklerózis (szkleroderma)2 toboroz
• Akut mieloid leukémia (AML)1 toboroz
• Bronchiectasis1 toboroz
• Chronic spontaneous urticaria1 toboroz
• Deep vein thrombosis and pulmonary embolism1 toboroz
• Diabéteszes retinopátia1 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)1 toboroz
• Epilepszia1 toboroz
• Gaucher-kór1 toboroz
• HIV-fertőzés1 toboroz
• Hólyagrák1 toboroz
• Idiopátiás tüdőfibrózis1 toboroz
• Köpenysejtes limfóma1 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)1 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)1 toboroz
• Máj- és epeúti rák1 toboroz
• Méhnyakrák1 toboroz
• Méhtestrák1 toboroz
• Melanóma1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Myasthenia gravis1 toboroz
• Neuroendokrin daganatok1 toboroz
• Pikkelysömör1 toboroz
• Primer biliáris cholangitis (PBC)1 toboroz
• Spinális izomatrófia (SMA)1 toboroz
• Tripla negatív emlőrák1 toboroz

Lezárt vizsgálatok

• Fut, nem toboroz

  A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease

  NCT07246941· 1. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

  NCT06991114· 2. fázis· Artiva Biotherapeutics, Inc.· Forrás

• Lezárult

  A Study of the Efficacy and Safety of Efgartigimod in Patients with Primary Sjögren's Syndrome (pSjD) (UNITY)

  NCT06684847· 3. fázis· Argenx· Forrás

• Fut, nem toboroz

  Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)

  NCT06726265· 3. fázis· Immutep S.A.S.· Forrás

• Lezárult

  Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been Treated

  2024-512505-66-00· 2/3. fázis· Gilead Sciences Inc.· Forrás

• Fut, nem toboroz

  Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

  NCT06806293· 3. fázis· AbbVie· Forrás

• Fut, nem toboroz

  A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)

  NCT06687369· 3. fázis· mAbxience Research S.L.· Forrás

• Lezárult

  A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjögren’s Syndrome

  NCT06312020· 2. fázis· Horizon Therapeutics Ireland Designated Activity Company· Forrás

• Fut, nem toboroz

  A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

  NCT06470048· 2. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  A study to evaluate the efficacy and safety of subcutaneous sonelokimab compared with placebo in adult participants with moderate to severe hidradenitis suppurativa

  2024-511360-87-00· 3. fázis· MoonLake Immunotherapeutics AG· Forrás

• Fut, nem toboroz

  A Phase 3 study of belrestotug plus dostarlimab compared with placebo plus pembrolizumab in previously untreated PD L1 high NSCLC

  2023-504753-12-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás

• Toboroz

  A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  NCT06585787· 3. fázis· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Forrás

• Fut, nem toboroz

  A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis

  NCT06558279· 3. fázis· argenx· Forrás

• Lezárult

  A study to find how well Dazodalibep works and how safe it is in participants with Sjögren’s Syndrome

  2023-503923-24-00· 3. fázis· Horizon Therapeutics Ireland Designated Activity Company· Forrás

• Fut, nem toboroz

  A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work

  NCT06290128· 3. fázis· Sanofi· Forrás

• Fut, nem toboroz

  A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis

  NCT06298552· 3. fázis· argenx· Forrás

• Lezárult

  Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR

  NCT06130540· 1. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

  NCT06104124· 3. fázis· Amgen· Forrás

• Fut, nem toboroz

  A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

  NCT06260163· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)

  NCT05877547· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.

  NCT05907057· 3. fázis· Servier Affaires Médicales· Forrás

• Toboroz

  Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

  NCT05714085· 2/3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

  NCT05819398· 2/3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Cardiomyopathy

  NCT05582395· 3. fázis· Myokardia Inc.· Forrás

• Lezárult

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).

  NCT05742802· 3. fázis· AstraZeneca· Forrás

• Lezárult

  A Open-label Study to Evaluate the Efficacy, Safety, Tolerability of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis

  NCT04781543· 2. fázis· Horizon Therapeutics Ireland Designated Activity Company· Forrás

• Lezárult

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· 3. fázis· Bayer· Forrás

• Lezárult

  A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

  NCT05523167· 2/3. fázis· argenx· Forrás

• Fut, nem toboroz

  Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer

  NCT05502237· 3. fázis· Gilead Sciences· Forrás

• Lezárult

  GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)

  NCT05189210· 2. fázis· GemVax & Kael· Forrás

• Fut, nem toboroz

  A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT05242484· 2. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Bemarituzumab plus Chemotherapy and Nivolumab versus Chemotherapy and Nivolumab Alone (FORTITUDE-102)

  NCT05111626· 3. fázis· Amgen Inc.· Forrás

• Leállították

  Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

  NCT05268289· 2. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome

  NCT05350072· 3. fázis· Novartis Pharmaceuticals· Forrás

• Fut, nem toboroz

  Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)

  NCT05263934· 3. fázis· GlaxoSmithKline· Forrás

• Lezárult

  A Phase 3 Study of Sotatercept in Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension (PAH) Patients.

  NCT04811092· 3. fázis· Acceleron Pharma Inc.· Forrás

• Lezárult

  Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy

  NCT05206513· 3. fázis· Neurocrine Biosciences· Forrás

• Fut, nem toboroz

  A Study of Rusfertide in Adults With Polycythemia Vera (PV)

  NCT05210790· 3. fázis· Protagonist Therapeutics, Inc.· Forrás

• Lezárult

  Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

  NCT05052801· 3. fázis· Amgen· Forrás

• Lezárult

  Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations

  NCT05166889· 3. fázis· AstraZeneca· Forrás

• Lezárult

  A study to investigate the safety and efficacy of AMX0035 in patients with Amyotrophic Lateral Sclerosis

  NCT05021536· 3. fázis· Amylyx Pharmaceuticals Inc.· Forrás

• Fut, nem toboroz

  Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  NCT05089734· 3. fázis· Gilead Sciences· Forrás

• Lezárult

  A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis

  2023-509782-20-00· 2. fázis· Horizon Therapeutics Ireland Designated Activity Company· Forrás

• Lezárult

  Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA)

  NCT04930094· 3. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

  NCT04987203· 3. fázis· AVEO Pharmaceuticals, Inc.· Forrás

• Lezárult

  Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT05016882· 2. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

  NCT05021835· 3. fázis· Novo Nordisk A/S· Forrás

• Fut, nem toboroz

  A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease

  NCT04929210· 4. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  A Long-term Follow-up Study of Sotatercept for PAH Treatment

  NCT04796337· 3. fázis· Acceleron Pharma Inc.· Forrás

Showing 50 of 66.